BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 4 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 4 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
AlphaGraphs

Earnings preview: What’s in store for L Brands in Q2?

L Brands Inc. (NYSE: LB) is slated to report second quarter 2019 earnings results on Wednesday, August 21, after regular trading hours. Analysts have projected earnings of $0.19 per share on revenue of $2.96 billion. L Brands has been struggling with slow sales in its Victoria’s Secret division and the company will need a new […]

August 18, 2019 2 min read

L Brands Inc. (NYSE: LB) is slated to report second quarter 2019 earnings results on Wednesday, August 21, after regular trading hours. Analysts have projected earnings of $0.19 per share on revenue of $2.96 billion.

L Brands has been struggling with slow sales in its Victoria’s Secret division and the company will need a new strategy in terms of assortment and marketing to revive the brand’s performance. The Bath & Body Works division has performed well, delivering consistent sales growth over the past couple of quarters. This trend is expected to continue in the second quarter.

L Brands reports first quarter 2019 earnings results

While Bath & Body Works has posted double-digit comp
sales growth consistently over the past few quarters, Victoria’s Secret has
seen declines in comps. This is likely to continue in the second quarter as
well. The weakness in Victoria’s Secret continues to weigh on the topline
results. The company is also seeing higher expenses which is a cause of
concern.

Earlier this year, L Brands closed all Henri Bendel stores and website and sold La Senza to an affiliate of the private equity firm Regent LP in order to focus more on its core segments.

Also see: L Brands Q2 2019 Earnings Conference Call Transcript

ADVERTISEMENT

In the first quarter of 2019, L Brands beat revenue and earnings expectations. Net sales remained flat at $2.6 billion while EPS declined 18% to $0.14. Analysts had forecast revenue of $2.5 billion and earnings breakeven. Comp sales were flat.

For the second quarter of 2019, L Brands has guided for EPS
of $0.15-0.20. For full-year 2019, the company raised its earnings outlook to a
range of $2.30-2.60 from the previous range of $2.20-2.60.

L Brands’ shares have fallen 22% so far this year and 11% in the past three months. The majority of analysts have rated the stock as Hold and the average price target is $28.64.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT